Mostrar el registro sencillo del ítem

dc.contributor.author
Marin, Gustavo Horacio  
dc.date.available
2020-06-24T22:00:22Z  
dc.date.issued
2020-03  
dc.identifier.citation
Marin, Gustavo Horacio; Facts and reflections on COVID-19 and anti-hypertensives drugs; Japan Medical Society; Drug Discoveries & Therapeutics; 14; 2; 3-2020; 104-107  
dc.identifier.issn
1881-7831  
dc.identifier.uri
http://hdl.handle.net/11336/108169  
dc.description.abstract
Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensivedrug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin IIreceptor blockers (e.g. losartan), many patients from South America, Central America or Spain,have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominousconsequences due to this drop out. For this reason, it is necessary to quickly warn about thissituation and the risks associated with it.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Japan Medical Society  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
COVID-19  
dc.subject
Medicines  
dc.subject
Side effects  
dc.subject
ACE-2  
dc.subject.classification
Farmacología y Farmacia  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Facts and reflections on COVID-19 and anti-hypertensives drugs  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2020-06-24T21:44:50Z  
dc.journal.volume
14  
dc.journal.number
2  
dc.journal.pagination
104-107  
dc.journal.pais
Japón  
dc.journal.ciudad
Tokyo  
dc.description.fil
Fil: Marin, Gustavo Horacio. Universidad Nacional de La Plata; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.journal.title
Drug Discoveries & Therapeutics  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.5582/ddt.2020.01017  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.jstage.jst.go.jp/article/ddt/14/2/14_2020.01017/_article